Literature DB >> 2971701

Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty.

M Cohen1, R Charney, R Hershman, V Fuster, R Gorlin.   

Abstract

From a cohort of patients referred for elective transluminal coronary angioplasty, a subset of patients was evaluated to determine whether revascularization using coronary angioplasty could salvage chronically ischemic myocardium. Reversible chronic ischemic left ventricular dysfunction was identified by a severe wall motion abnormality at rest and at least one of the following: 1) persistent angina pectoris; 2) postextrasystolic ventricular contraction potentiation of motion in the asynergic zone on baseline ventriculogram; and 3) thallium-201 uptake in the asynergic zone. Twelve patients were identified as having reversible chronic ischemia and underwent coronary angioplasty. Their mean age was 63 +/- 11 years and duration of symptoms 8.3 +/- 9.7 weeks. Immediate pre- and postangioplasty left ventriculograms were obtained. Regional wall motion was analyzed using a radial axis model, and global ejection fraction was calculated. After angioplasty, tension development (heart rate-systolic pressure product) increased in the absence of an increase in left ventricular end-diastolic pressure. Global ejection fraction increased from 46 +/- 20 to 62 +/- 19% (p less than 0.005). The percent of left ventricular diastolic perimeter showing asynergy decreased from 29 +/- 11 to 10 +/- 13% (p less than 0.005). During follow-up ranging from 6 to 51 months, sudden death occurred in one patient who had had no improvement in wall motion after angioplasty, repeat angioplasty was performed in three patients and eight patients remained asymptomatic. Application of easily obtainable clinical data identifies a subset of patients with chronically ischemic myocardium. Coronary angioplasty in such patients is useful in salvaging hibernating myocardium.

Entities:  

Mesh:

Year:  1988        PMID: 2971701     DOI: 10.1016/0735-1097(88)92599-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Left ventricular electromechanical mapping: a case study of functional assessment in coronary intervention.

Authors:  E C Perin; G V Silva; R Sarmento-Leite
Journal:  Tex Heart Inst J       Date:  2000

Review 2.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 3.  Recovery of myocardial function in the hibernating heart.

Authors:  C W Hamm
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

4.  Evaluation of parameters for the assessment of regional myocardial contractile function during asynchronous left ventricular contraction.

Authors:  B D Guth; R Schulz; G Heusch
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

Review 5.  Stunning of the myocardium: an update.

Authors:  E Braunwald
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 6.  Reversible congestive heart failure caused by myocardial hibernation.

Authors:  J M Wilson
Journal:  Tex Heart Inst J       Date:  1999

Review 7.  Hibernating myocardium in patients with coronary artery disease: identification and clinical importance.

Authors:  R Ferrari; G La Canna; R Giubbini; O Alfieri; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 8.  Myocardial viability.

Authors:  Y Birnbaum; R A Kloner
Journal:  West J Med       Date:  1996-12

9.  Coronary blood flow, metabolism, and function in dysfunctional viable myocardium before and early after surgical revascularisation.

Authors:  F Alamanni; A Parolari; A Repossini; E Doria; F Bortone; J Campolo; M Pepi; E Sisillo; M Naliato; R Bigi; P Biglioli; O Parodi
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

10.  Increase in serum cardiac myosin light chain I associated with elective percutaneous transluminal coronary angioplasty in patients with ischemic heart disease.

Authors:  H Tanaka; K Gotoh; Y Yagi; T Tanaka; K Yamashita; T Suzuki; S Hirakawa
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.